Form 4 for VREX Varex Imaging Corp
Accepted 2026-09-15 17:44:51 ET · period of report 2026-09-11 · accession 0001607969-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-15 17:44 | 2026-09-11 | VREX | Maheshwari Shubham | CFO | M - OptEx | $13.61 | +160.9K | 270.0K | +148% | +$2.19M |
| D | 2026-09-15 17:44 | 2026-09-11 | VREX | Maheshwari Shubham | CFO | S - Sale+OE | $18.46 | -130.0K | 140.0K | -48% | -$2.40M |
| D | 2026-09-15 17:44 | 2026-09-11 | VREX | Maheshwari Shubham | CFO | M - OptEx | $0.00 | -160.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | M | A | 160,944 | $13.61 | 269,972 | D | — | — | (F1) Includes 2,137 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person. |
| 2 | Common | Common Stock | 2026-09-11 | S | D | 130,000 | $18.46 | 139,972 | D | — | — | (F2) The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested options. The shares were sold solely to cover the aggregate exercise price, applicable tax withholdings and broker's fees. The reporting person retained all remaining shares acquired upon exercise. (F3) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.460 to $18.470. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-09-11 | M | D | 160,944 | $0.00 | 0 | D | $13.61 · — to 2030-08-15 | 160,944 Common Stock | (F4) These Performance Stock Options were subject to a four-year vesting schedule. 25% of the total number of options vested on August 15, 2021 and the remaining options vested monthly thereafter on a pro rata basis. |